SalioGen Therapeutics

About:

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.

Website: https://saliogen.com

Twitter/X: saliogen

Top Investors: Fidelity, T. Rowe Price, PBM Capital Group, EPIQ Capital Group, D1 Capital Partners

Description:

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders. Its Gene Coding approach is guided by our Exact DNA Integration Technology (EDIT) platform, a genome engineering technology that leverages proprietary mammal-derived enzymes they call Saliogase. With broad applicability, non-viral delivery capabilities of any size gene, and significant manufacturing advantages, EDIT has the potential to transform the treatment paradigm for inherited disorders and beyond.